上海莼试生物技术有限公司
   
菜单 Close 公司首页 公司介绍 公司动态 产品展厅 证书荣誉 联系方式 在线留言
您当前的位置: 网站首页 > 产品展厅 >抗体 >μ-型 受体抗体规格
产品展厅
μ-型 受体抗体规格
  • 品牌:上海莼试
  • 产地:进口、国产
  • 货号:CS10022
  • 发布日期: 2018-12-28
  • 更新日期: 2025-11-11
产品详请
产地 进口、国产
品牌 上海莼试
保存条件 Store at -20 °C
货号 CS10022
应用范围 WB=1:100-500 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
CAS编号
抗体名 Anti-mu Opioid receptor
克隆性
靶点 详见说明书
适应物种 详见说明书
形态 详见说明书
宿主 详见说明书
亚型 IgG
标识物 详见说明书
浓度 1mg/1ml%
免疫原 KLH conjugated synthetic peptide derived from human mu Opioid receptor

中文名称  μ-型阿片受体抗体规格 

英文名称  Anti-mu Opioid receptor

     LMOR; MOR 1; mor; MOR1; Mu opiate receptor; mu type opioid receptor; Mu type opioid receptor MOR 1; muOR; Opioid receptor mu 1; Opioid receptor mu; OPRM; OPRM1; OPRM_HUMAN.

产品属性:

μ-型阿片受体抗体规格       1mg/1ml

  0.1ml/100μg 0.2ml/200μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Guinea Pig

产品类型   一抗  

研究领域    免疫学 神经生物学 信号转导 转录调节因子 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 45kDa 

       Lyophilized or Liquid

  KLH conjugated synthetic peptide derived from human mu Opioid receptor

      IgG

纯化方法   affinity purified by Protein A

   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

μ-型阿片受体抗体规格 产品应用   WB=1:100-500 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

(石蜡切片需做抗原修复) 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 Three types of opioid receptors have been cloned: mu, delta, and kappa. Opioid receptors are seven transmembrane G-protein coupled receptors. They share a high degree of homology and are most divergent at the N- and C-termini. Activation of mu opioid receptors leads to a decrease in neuronal excitability. Most actions of exogenous opioids, such as morphine, are mediated through the mu opioid receptor, including analgesia, tolerance and reward. In general, opioids modulate numerous central and peripheral processes including pain perception,neuroendocrine secretion and the immune response. The opioid signal is transduced from receptors through G proteins to various different effectors. Subsequent to G protein activation, several effectors are known to orchestrate the opioid signal. For example, activation of opioid receptors increases phosphatidylinositol turnover, activates K+ channels and reduces adenylyl cyclase and Ca++ channel activities.

Function : Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effectors. The agonist-and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extend to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15. They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B. Also couples to adenylate cyclase stimulatory G alpha proteins. The selective temporal coupling to G-proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4. Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization. Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G-protein thus terminating signal transduction. The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins. The activation of the ERK pathway occurs either in a G-protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist-specific receptor phosphorylation. Acts as a class A G-protein coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling. Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G-protein coupling. Endogenous ligands induce rapid desensitization, endocytosis and recycling whereas morphine induces only low desensitization and endocytosis. Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties. Involved in neurogenesis. Isoform 12 couples to GNAS and is proposed to be involved in excitatory effects. Isoform 16 and isoform 17 do not bind agonists but may act through oligomerization with binding-competent OPRM1 isoforms and reduce their ligand binding activity.

Subunit : Forms homooligomers and heterooligomers with other GPCRs, such as OPRD1, OPRK1, OPRL1, NPFFR2, ADRA2A, SSTR2, CNR1 and CCR5 (probably in dimeric forms). Interacts with PPL; the interaction disrupts agonist-mediated G-protein activation. Interacts (via C-terminus) with DNAJB4 (via C-terminus). Interacts with calmodulin; the interaction inhibits the constitutive activity of OPRM1; it abolishes basal and attenuates agonist-stimulated G-protein coupling. Interacts with FLNA, PLD2, RANBP9 and WLS. Interacts with GPM6A, RTP4, SYP, GNAS, RGS9, RGS17, RGS20, RGS4, PPP1R9B and HINT1 (By similarity).

Subcellular Location : Cell membrane; Multi-pass membrane protein.

Isoform 12: Cytoplasm.

Tissue Specificity : Expressed in brain. Isoform 16 and isoform 17 are detected in brain.

Post-translational modifications : Phosphorylated. Differentially phosphorylated in basal and agonist-induced conditions. Agonist-mediated phosphorylation modulates receptor internalization. Phosphorylated by ADRBK1 in a agonist-dependent manner. Phosphorylation at Tyr-168 requires receptor activation, is dependent on non-receptor protein tyrosine kinase Src and results in a decrease in agonist efficacy by reducing G-protein coupling efficiency. Phosphorylated on tyrosine residues; the phosphorylation is involved in agoinist-induced G-protein-indepenedent receptor down-regulation. Phosphorylation at Ser-377 is involved in G-protein-dependent but not beta-arrestin-dependent activation of the ERK pathway (By similarity).

Ubiquitinated. A basal ubiquitination seems not to be related to degradation. Ubiquitination is increased upon formation of OPRM1:OPRD1 oligomers leading to proteasomal degradation; the ubiquitination is diminished by RTP4 (By similarity).

Similarity : Belongs to the G-protein coupled receptor 1 family.

Database links : UniProtKB/Swiss-Prot: P35372.2

 

实验流程:

全、新、优、品、好四大特点:

μ-型阿片受体抗体规格 全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材,抗体、培养基、ATCC细胞等,基本上各种科研所需产品在我司都能找到。

新:产品更新速度较快,基本上每周都有新产品出现。

优:产品质量好,投诉比较少。

好:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

技术外包服务:

μ-型阿片受体抗体规格 分子生物学:质粒抽提、PCRQ-PCRRT-PCR、分子生物学:基因合成、引物合成、基因测序、载体构建等

蛋白工程:原核、哺乳动物蛋白表达系统等

病毒包装:腺病毒、慢病毒等

抗体工程:磁珠分选、病理染色、WBELISAIPIFIHCFACSConfocal等等

细胞工程:细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。

正在热销的相关产品:

Anti-EphA2 R/FITC 荧光素标记兔抗人、大、小鼠酪氨酸蛋白激酶受体A2抗体IgGMulti-class antibodies规格: 0.2ml

Anti-MSK1/FITC 荧光素标记有丝分裂原和应激活化型蛋白激酶1抗体IgGMulti-class antibodies规格: 0.2ml

Rhesus antibody Rh C1orf52 1号染色体开放阅读框52抗体 规格 0.2ml

TNF-Alpha(Tumor Necrosis Factor-Alpha) 人坏死因子-α(多肽抗原) 0.5mg

High density lipoprotein 英文名称: 抗体 0.1ml

Rhesus antibody Rh RSV 合胞病毒抗体 规格 0.1ml

Anti-MSK1/FITC 荧光素标记有丝分裂原和应激活化型蛋白激酶1抗体IgGMulti-class antibodies规格: 0.2ml

IL-6 ELISA KIT 大鼠白介素-6Multi-class antibodies规格: 48T

Anti-D-DIMER 交联纤维蛋白二聚体抗体Multi-class antibodies规格: 0.2ml

Rhesus antibody Rh NEEP21 NEEP21蛋白抗体 规格 0.2ml

Human transthyretin,TTR ELISA Kit 人转甲状腺素蛋白 96T

TMEM158 英文名称: 跨膜蛋白158抗体 0.2ml

Cancer testis antigen 65 英文名称: /抗原65 0.2ml

Anti-D-DIMER 交联纤维蛋白二聚体抗体Multi-class antibodies规格: 0.2ml

ACE ELISA Kit 大鼠紧张素转化酶Multi-class antibodies规格: 48T

Anti-Bcl-10(phospho Ser218)/FITC 荧光素标记兔抗人、大、小鼠磷酸化Bcl-10抗体IgGMulti-class antibodies规格: 0.2ml

Rhesus antibody Rh ERN2 内质网核信号转导蛋白2抗体 规格 0.2ml

Mouse angiotension II ,ANG- II ELISA Kit 小鼠紧张素Ⅱ 96T

MYH7B 英文名称: 肌球蛋白重链7抗体 0.2ml

FE65 英文名称: 铁蛋白Fe65抗体 0.1ml

Anti-Bcl-10(phospho Ser218)/FITC 荧光素标记兔抗人、大、小鼠磷酸化Bcl-10抗体IgGMulti-class antibodies规格: 0.2ml

TNFSF8 Protein Rat 重组大鼠 CD153 / CD30L / TNFSF8 蛋白 (Fc 标签)

EC9706

LIF Others Mouse 小鼠 LIF 人细胞裂解液 (阳性对照)

SW620人细胞 SW620 human colon cancer cells L-15+10%FBS

人上皮细胞;Hep-2

人胚胎绒毛细胞(HAF)(1×106 ) 细胞名称 种属

CL-0430RS1(大鼠皮肤成纤维样细胞)5×106cells/瓶×2

IL22RA1 Others Canine 狗 IL22RA1 / IL22R 人细胞裂解液 (阳性对照)

人食道上皮细胞RNAHEEpiC miRNA5 μg

兔间变表皮鳞株;VX2 细胞,22RV1细胞 MDCK superdome细胞,狗肾细胞隆突型

人永生化淋巴细胞;CNLMG-B5537LC

HA Others H3N2 甲型 H3N2 (A/Aichi/2/1968) 血凝素HA1 (Hemagglutinin) 人细胞裂解液 (阳性对照)

μ-型阿片受体抗体规格 TNFSF8 Protein Rat 重组大鼠 CD153 / CD30L / TNFSF8 蛋白 (Fc 标签)

EC9706

LIF Others Mouse 小鼠 LIF 人细胞裂解液 (阳性对照)

SW620人细胞 SW620 human colon cancer cells L-15+10%FBS

人上皮细胞;Hep-2

人胚胎绒毛细胞(HAF)(1×106 ) 细胞名称 种属

 


联系方式
手机:13585831301
Q Q: